OTCMKTS:CBBT

Cerebain Biotech Competitors

$0.03
0.00 (0.00 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.03
$0.03
50-Day Range
$0.03
MA: $0.07
$0.12
52-Week Range
$0.00
Now: $0.03
$0.47
Volume15.83 million shs
Average Volume18.08 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Cerebain Biotech (OTCMKTS:CBBT) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and LBTSF

Should you be buying CBBT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Cerebain Biotech, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Almirall (LBTSF).

Cerebain Biotech (OTCMKTS:CBBT) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for Cerebain Biotech and (DDXS), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cerebain Biotech0000N/A
(DDXS)0000N/A

Earnings and Valuation

This table compares Cerebain Biotech and (DDXS)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerebain BiotechN/AN/AN/AN/AN/A
(DDXS)N/AN/AN/AN/AN/A

Profitability

This table compares Cerebain Biotech and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cerebain BiotechN/AN/AN/A
(DDXS)N/AN/AN/A

Cerebain Biotech (OTCMKTS:CBBT) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Profitability

This table compares Cerebain Biotech and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cerebain BiotechN/AN/AN/A
(TNGN)N/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations for Cerebain Biotech and (TNGN), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cerebain Biotech0000N/A
(TNGN)0000N/A

Valuation & Earnings

This table compares Cerebain Biotech and (TNGN)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerebain BiotechN/AN/AN/AN/AN/A
(TNGN)N/AN/AN/AN/AN/A

Cerebain Biotech (OTCMKTS:CBBT) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends.

Earnings & Valuation

This table compares Cerebain Biotech and Abattis Bioceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerebain BiotechN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares Cerebain Biotech and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cerebain BiotechN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for Cerebain Biotech and Abattis Bioceuticals, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cerebain Biotech0000N/A
Abattis Bioceuticals0000N/A

ADiTx Therapeutics (NASDAQ:ADTX) and Cerebain Biotech (OTCMKTS:CBBT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

Profitability

This table compares ADiTx Therapeutics and Cerebain Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ADiTx TherapeuticsN/AN/AN/A
Cerebain BiotechN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for ADiTx Therapeutics and Cerebain Biotech, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ADiTx Therapeutics00103.00
Cerebain Biotech0000N/A

Earnings and Valuation

This table compares ADiTx Therapeutics and Cerebain Biotech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADiTx TherapeuticsN/AN/AN/AN/AN/A
Cerebain BiotechN/AN/AN/AN/AN/A

Summary

ADiTx Therapeutics beats Cerebain Biotech on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Cerebain Biotech (OTCMKTS:CBBT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Valuation and Earnings

This table compares Algernon Pharmaceuticals and Cerebain Biotech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
Cerebain BiotechN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for Algernon Pharmaceuticals and Cerebain Biotech, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
Cerebain Biotech0000N/A

Profitability

This table compares Algernon Pharmaceuticals and Cerebain Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
Cerebain BiotechN/AN/AN/A

Cerebain Biotech (OTCMKTS:CBBT) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership.

Valuation & Earnings

This table compares Cerebain Biotech and Almirall's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerebain BiotechN/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Cerebain Biotech and Almirall, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cerebain Biotech0000N/A
Almirall01102.50

Profitability

This table compares Cerebain Biotech and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cerebain BiotechN/AN/AN/A
AlmirallN/AN/AN/A

Summary

Almirall beats Cerebain Biotech on 1 of the 1 factors compared between the two stocks.


Cerebain Biotech Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.52flat$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.12flat$0.00N/A0.00
Almirall logo
LBTSF
Almirall
0.5$15.15flat$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.07flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.56flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00News Coverage
BMEA
Biomea Fusion
0.0$16.79flat$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18flat$0.00N/A0.00News Coverage
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$23.20flat$0.00N/A0.00
CELZ
Creative Medical Technology
0.5$0.03flat$0.00N/A0.00
Cybin logo
CLXPF
Cybin
0.7$1.17flat$0.00N/A0.00News Coverage
Gap Up
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.01flat$0.00N/A0.00Gap Down
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.14flat$0.00N/A0.00News Coverage
Gap Up
GB Sciences logo
GBLX
GB Sciences
0.5$0.05flat$0.00N/A0.00News Coverage
Genfit logo
GNFTF
Genfit
0.5$4.52flat$0.00N/A0.00
GMXAY
GENMAB A/S/S
0.5$35.59flat$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$69.40flat$0.00N/A0.00News Coverage
HALB
Halberd
0.0$0.04flat$0.00N/A0.00News Coverage
Gap Up
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.57flat$0.00N/A0.00Gap Up
Idorsia logo
IDRSF
Idorsia
0.5$28.40flat$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.24flat$0.00N/A0.00
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.04flat$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.73flat$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.27flat$0.00N/A0.00
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.24flat$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$25.19flat$0.00N/A0.00
MPSYF
MorphoSys
0.0$92.50flat$0.00N/A0.00Gap Down
NRNVF
Nordic Nanovector ASA
0.0$1.64flat$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$65.96flat$0.00N/A0.00Gap Down
BPSR
Organicell Regenerative Medicine
0.5$0.05flat$0.00N/A0.00Gap Down
Oxurion logo
TBGNF
Oxurion
0.5$2.94flat$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11flat$0.00N/A0.00
PTEO
Proteo
0.5$0.09flat$0.00N/A0.00
PROT
Proteonomix
0.5$0.01flat$0.00N/A0.00Gap Down
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.19flat$0.00N/A0.00Gap Down
PureTech Health logo
PTCHF
PureTech Health
0.0$5.71flat$0.00N/A0.00Gap Up
RCPHF
Recipharm AB (publ)
1.0$16.05flat$0.00N/A0.00High Trading Volume
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.